Borisy Alexis
Insider CIK 1319446 · FMI Director · BPMC Director · RVMD Director · EDIT Director · PBLS Director · MGTA Director · RLAY Director · TNGX Director · EQRX Executive Chairman, Director · OPK Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 3,127 | — | $0 | 3,127 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2026-06-18 | 2026-06-23 | 1,191 | — | $0 | 2,340,075 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 162,221 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-15 | 105,414 | — | $0 | 105,414 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 32,947 | — | $0 | 32,947 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 20,215 | — | $0 | 20,215 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,570 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 7,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,875 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 4,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,300 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 74,160 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 3,902 | — | $0 | 74,160 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2025-06-26 | 2025-06-30 | 11,574 | — | $0 | 11,574 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2025-06-26 | 2025-06-30 | 3,142 | — | $0 | 2,338,884 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-06-18 | 2025-06-24 | 3,902 | $128.12 | $499.9K | 78,062 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-06 | 136,681 | — | $0 | 136,681 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 37,500 | — | $0 | 37,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2025-06-05 | 2025-06-09 | 6,250 | — | $0 | 17,500 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 16,700 | — | $0 | 16,700 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2024-06-20 | 2024-06-28 | 15,955 | — | $0 | 15,955 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2024-06-20 | 2024-06-24 | 4,800 | — | $0 | 2,336,294 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2024-06-20 | 2024-06-28 | 4,248 | — | $0 | 2,335,742 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-06-12 | 2024-06-14 | 4,570 | — | $0 | 4,570 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-06-12 | 2024-06-14 | 2,242 | — | $0 | 74,160 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 37,500 | — | $0 | 37,500 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2024-06-05 | 2024-06-07 | 6,250 | — | $0 | 11,250 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2024-06-03 | 2024-06-05 | 102,225 | — | $0 | 102,225 | SEC↗ |
| EQRX EQRx, Inc. | D To issuer deriv | 2023-11-09 | 2023-11-09 | 2,892,491 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | D To issuer deriv | 2023-11-09 | 2023-11-09 | 2,194,499 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2023-11-09 | 2023-11-14 | 296,039 | — | $0 | 296,039 | SEC↗ |
| EQRX EQRx, Inc. | D To issuer | 2023-11-09 | 2023-11-09 | 18,810,000 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2023-11-09 | 2023-11-14 | 2,091,672 | — | $0 | 2,331,494 | SEC↗ |
| OPK OPKO HEALTH, INC. | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-06-21 | 2023-06-23 | 5,300 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-06-21 | 2023-06-23 | 2,600 | — | $0 | 71,918 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 18,400 | — | $0 | 18,400 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2023-06-08 | 2023-06-12 | 5,200 | — | $0 | 239,822 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2023-05-31 | 2023-06-01 | 66,055 | — | $0 | 66,055 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2023-01-01 | 2023-01-04 | 15,148 | — | $0 | 2,892,491 | SEC↗ |
| OPK OPKO HEALTH, INC. | A Award deriv | 2022-07-14 | 2022-07-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-06-21 | 2022-06-30 | 0 | — | $0 | 5,300 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-06-21 | 2022-06-30 | 2,600 | — | $0 | 69,318 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 18,400 | — | $0 | 18,400 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2022-06-16 | 2022-06-17 | 5,200 | — | $0 | 54,918 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2022-05-27 | 2022-05-27 | 41,597 | — | $0 | 41,597 | SEC↗ |
| OPK OPKO HEALTH, INC. | A Award deriv | 2022-05-09 | 2022-05-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OPK OPKO HEALTH, INC. | A Award deriv | 2022-05-09 | 2022-05-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| OPK OPKO HEALTH, INC. | A Award | 2022-05-09 | 2022-05-11 | 312,612 | — | $0 | 312,612 | SEC↗ |
| OPK OPKO HEALTH, INC. | A Award | 2022-05-09 | 2022-05-13 | 312,612 | — | $0 | 312,612 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2021-12-17 | 2021-12-21 | 2,877,343 | — | $0 | 2,877,343 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2021-12-17 | 2021-12-21 | 2,194,499 | — | $0 | 2,194,499 | SEC↗ |
| EQRX EQRx, Inc. | A Award | 2021-12-17 | 2021-12-21 | 18,810,000 | — | $0 | 18,810,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | J Other | 2021-08-26 | 2021-09-23 | 4,100 | — | $0 | 4,100 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2021-06-22 | 2021-06-24 | 12,659 | — | $0 | 12,659 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2021-06-22 | 2021-06-24 | 3,617 | — | $0 | 49,718 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-06-02 | 2021-06-04 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-06-02 | 2021-06-04 | 2,250 | — | $0 | 66,718 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 18,188 | — | $0 | 18,188 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | A Award deriv | 2021-05-19 | 2021-05-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | J Other | 2021-03-11 | 2021-03-15 | 28,538 | — | $0 | 234,175 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | J Other | 2021-02-19 | 2021-02-19 | 30,194 | — | $0 | 205,637 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | J Other | 2021-02-05 | 2021-02-09 | 70,956 | — | $0 | 175,443 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion deriv | 2020-07-20 | 2020-07-21 | 371,027 | — | $0 | 0 | SEC↗ |
| RLAY Relay Therapeutics, Inc. | C Conversion | 2020-07-20 | 2020-07-21 | 104,487 | — | $0 | 104,487 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-06-24 | 2020-06-26 | 4,500 | — | $0 | 4,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-06-24 | 2020-06-26 | 2,250 | — | $0 | 64,468 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2020-06-19 | 2020-06-23 | 1,312 | — | $0 | 62,218 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 6,329 | — | $0 | 6,329 | SEC↗ |
| RVMD Revolution Medicines, Inc. | A Award | 2020-06-17 | 2020-06-19 | 1,808 | — | $0 | 1,808 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 18,188 | — | $0 | 18,188 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-06-27 | 2019-07-01 | 10,909 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2019-06-27 | 2019-07-01 | 10,909 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-27 | 2019-07-01 | 968 | $91.55 | $88.6K | 60,906 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-06-27 | 2019-07-01 | 10,909 | $19.53 | $213.1K | 71,815 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2019-06-27 | 2019-07-01 | 20,850 | $92.03 | $1.92M | 61,874 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2019-06-27 | 2019-07-01 | 10,909 | $46.02 | $502.0K | 82,724 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 1,312 | — | $0 | 1,312 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-06-19 | 2019-06-20 | 4,875 | — | $0 | 4,875 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-11 | 18,188 | — | $0 | 18,188 | SEC↗ |
| FMI Foundation Medicine, Inc. | H Expire deriv | 2018-07-31 | 2018-08-02 | 13,385 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | U Tender | 2018-07-31 | 2018-08-02 | 73,173 | $137.00 | $10.02M | 0 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 0 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion deriv | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 0 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | C Conversion | 2018-06-25 | 2018-06-27 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-06-21 | 2018-06-25 | 7,500 | — | $0 | 29,318 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-05-11 | 2018-05-14 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-05-10 | 2018-05-14 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-05-09 | 2018-05-11 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-05-07 | 2018-05-08 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-05-04 | 2018-05-08 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 10,909 | — | $0 | 21,818 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award | 2017-06-20 | 2017-06-22 | 5,786 | $40.05 | $231.7K | 73,173 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 11,538 | — | $0 | 11,538 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-02-07 | 2017-02-09 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-06-23 | 2016-06-27 | 10,909 | — | $0 | 10,909 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award | 2016-06-16 | 2016-06-20 | 12,075 | $19.93 | $240.7K | 67,387 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 0 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 0 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 0 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2016-02-08 | 2016-02-09 | 0 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-12-02 | 8,561 | — | $0 | 26,742 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award | 2015-06-18 | 2015-06-22 | 5,997 | $32.23 | $193.3K | 55,312 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2015-05-14 | 2015-05-15 | 448 | — | $0 | 49,315 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-04-07 | 2015-04-09 | 234,542 | $50.00 | $11.73M | 56,093 | SEC↗ |
| FMI Foundation Medicine, Inc. | S Sale | 2015-04-07 | 2015-04-16 | 241,768 | $50.00 | $12.09M | 48,867 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award deriv | 2014-06-18 | 2014-06-20 | 13,385 | — | $0 | 13,385 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2014-05-12 | 2014-05-14 | 10 | — | $0 | 290,635 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 1,106,194 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion deriv | 2013-09-30 | 2013-10-02 | 23,772,388 | — | $0 | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 276,548 | — | $0 | 6,569,645 | SEC↗ |
| FMI Foundation Medicine, Inc. | C Conversion | 2013-09-30 | 2013-10-02 | 5,943,097 | — | $0 | 6,293,097 | SEC↗ |